HedgeChatter

  • Home /
  • Tag Archives

NBY

NovaBay’s NeutroPhase(R) is Best in Class in Laboratory Study of 19 Top Commercial Wound Cleansers

[GlobeNewswire] – The In Vitro Study, Published in the Peer-Reviewed Journal Advances in Skin & Wound Care, Showed that NeutroPhase Kills Bacteria Quickly moreView todays social media effects on NBYView the latest stocks trending across Twitter. Click to view dashboardSee who NovaBay is hiring next, click here to view […]

February 17, 2014 Bystocknews , Comments Off on NovaBay’s NeutroPhase(R) is Best in Class in Laboratory Study of 19 Top Commercial Wound Cleansers read more

NovaBay Global Ophthalmology Study Enrolls First Patients in Brazil

[at noodls] – Press Releases EMERYVILLE, CA – April 8, 2013 BAYnovation Phase 2b Trial for the Treatment of Viral Conjunctivitis Spans Three Continents NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biotechnology … moreView todays social media effects on NBYView the latest stocks trending across Twitter. Click to view dashboardSee who NovaBay is hiring next, click here to view […]

April 8, 2013 Bystocknews , Comments Off on NovaBay Global Ophthalmology Study Enrolls First Patients in Brazil read more

Oculus And NovaBay: 100% Upside Potential

moreView todays social media effects on NBYView the latest stocks trending across Twitter. Click to view dashboardSee who NovaBay is hiring next, click here to view […]

April 1, 2013 Bystocknews , Comments Off on Oculus And NovaBay: 100% Upside Potential read more

NovaBay Pharmaceuticals Reports Fourth Quarter Financial Results and 2013 Clinical and Business Update

[at noodls] – Well Positioned in 2013 with Three Phase 2b Clinical Trials for Conjunctivitis, Impetigo and UCBE Advancing EMERYVILLE, Calif., March 14, 2013 — NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY), a biotechnology … moreView todays social media effects on NBYView the latest stocks trending across Twitter. Click to view dashboardSee who NovaBay is hiring next, click here to view […]

March 14, 2013 Bystocknews , Comments Off on NovaBay Pharmaceuticals Reports Fourth Quarter Financial Results and 2013 Clinical and Business Update read more

NovaBay Pharmaceuticals to Present at the 25th Annual ROTH Conference

[at noodls] – EMERYVILLE, CA – March 12, 2013 – NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biotechnology company focused on addressing a large unmet therapeutic needs of the global anti-infective market with … moreView todays social media effects on NBYView the latest stocks trending across Twitter. Click to view dashboardSee who NovaBay is hiring next, click here to view […]

March 12, 2013 Bystocknews , Comments Off on NovaBay Pharmaceuticals to Present at the 25th Annual ROTH Conference read more

NovaBay Names Keith Bley as Senior Vice President of Product Development

[at noodls] – – Behzad Khosrovi Retires After Ten-Year Career at NovaBay – EMERYVILLE, CA – March 11, 2013 – NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biotechnology company focused on addressing the large unmet … moreView todays social media effects on NBYView the latest stocks trending across Twitter. Click to view dashboardSee who NovaBay is hiring next, click here […]

March 11, 2013 Bystocknews , Comments Off on NovaBay Names Keith Bley as Senior Vice President of Product Development read more

NovaBay Receives Unique Globally Recognized International Nonproprietary Name Auriclosene for NVC-422

[at noodls] – – Data from Three Phase 2 Trials of Lead Aganocide Compound Anticipated in 2013 – – Phase 3 Registration Trials Expected in 2014 – EMERYVILLE, CA – February 20, 2013 – NovaBay® Pharmaceuticals, Inc. (NYSE … moreView todays social media effects on NBYView the latest stocks trending across Twitter. Click to view dashboardSee who NovaBay is hiring […]

February 20, 2013 Bystocknews , Comments Off on NovaBay Receives Unique Globally Recognized International Nonproprietary Name Auriclosene for NVC-422 read more